Stock Caveat Emptor Status Changes Monday, September 23,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Stock Caveat Emptor Status Changes Monday, September 23, 2013 05:13:24 AM

Date Symbol Company Name Tier Caveat Emptor Status Security Type
Sept 23, 2013 OODH Orion Diversified Holding Co Inc. OTC Pink Limited Removed Common Stock
Sept 20, 2013 CRVH Chilco River Holdings, Inc. OTC Pink No Information Added Common Stock
Sept 19, 2013 WSCO Wall Street Media Co, Inc. OTCQB Removed Common Stock
Sept 19, 2013 MNHG Millenium Holding Group, Inc. Grey Market Added Common Stock
Sept 19, 2013 MHLI Marshall Holdings International, Inc. Grey Market Added Common Stock
Sept 19, 2013 EMED MedCom USA, Inc. Grey Market Added Common Stock
Sept 19, 2013 CGXP Ceragenix Pharmaceuticals, Inc. Grey Market Added Common Stock
Sept 19, 2013 AVMC aVinci Media Corp. Grey Market Added Common Stock
Sept 19, 2013 AADI American Asset Development, Inc. Grey Market Added Common Stock
Sept 18, 2013 VMCT Virtual Medical Centre, Inc. Grey Market Added Common Stock
Sept 18, 2013 SIRCQ SiriCOMM, Inc. Grey Market Added Common Stock
Sept 18, 2013 SGCR Strategic Resources Ltd. Grey Market Added Common Stock
Sept 18, 2013 SDGS Secured Digital Storage Corp. Grey Market Added Common Stock
Sept 18, 2013 SBON Siboney Corp. Grey Market Added Common Stock
Sept 18, 2013 SARO SARS Corp. Grey Market Added Common Stock
Sept 18, 2013 RPMM RPM Technologies, Inc. Grey Market Added Common Stock
Sept 18, 2013 PTCHF Patch International, Inc. Grey Market Added Ordinary Shares
Sept 18, 2013 PLKH ProLink Holdings Corp. Grey Market Added Common Stock
Sept 18, 2013 PCWT Pacific Clean Water Technologies, Inc. OTCQB Added Common Stock
Sept 18, 2013 MMAB Municipal Mortgage & Equity, L.L.C. Grey Market Added Common Stock
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Lawsuit Against Everus Builds

Updated Category News Views 97

Investigation of Claims Against Everus Construction Group Faruqi & Faruqi, LLP, a well-respected national securities law firm, has initiated an investigation into potential claims associated with Everus Construction Group, Inc. (NYSE: ECG). The firm specializes in shareholder rights and is aiming to provide support to affected investors after concerning revelations about...

Continue Reading
Heilongjiang Forum 2025: Elevating Macao's Global Tourism Standing

Updated Category News Views 107

Global Tourism Economy Forum 2025: A Landmark Event The Global Tourism Economy Forum (GTEF) made its notable debut outside of Macao by hosting the 2025 edition in Heilongjiang province, China. This forum gathered influential figures from the tourism sector and various related industries, fostering discussions aimed at exploring new avenues for cooperation and growth....

Continue Reading
Nextracker and T1 Energy Collaboration Drives Solar Growth

Updated Category News Views 198

Nextracker and T1 Energy Join Forces to Strengthen Solar Production Nextracker Inc. (NASDAQ: NXT) has recently established a partnership with T1 Energy Inc. (NYSE: TE) aimed at revolutionizing solar manufacturing. This collaboration will see the integration of Nextracker's cutting-edge steel module frame technology into T1 Energy's upcoming solar manufacturing plant,...

Continue Reading
Nathan Ballentine Steps In as Regional VP at New American Funding

Updated Category News Views 175

New Leadership at New American Funding New American Funding (NAF), a prominent independent mortgage lender, has announced a significant appointment. Nathan Ballentine is joining the team as the Regional Vice President, where he will play a pivotal role in propelling growth and development within the state. His expertise will be crucial as the company seeks to deepen its...

Continue Reading
CSL Behring Secures Approval for ANDEMBRY® in Japan

Updated Category News Views 341

CSL Behring's Recent Approval for ANDEMBRY® CSL Behring has announced a significant medical milestone with the approval of ANDEMBRY® (garadacimab) subcutaneous (S.C.) injection 200mg pens in Japan. This groundbreaking therapy is a first-in-class monoclonal antibody specifically designed to inhibit activated Factor XII (FXIIa), a crucial initiator in the hereditary...

Continue Reading